UCLA Health researchers have developed a novel blood test that measures cell-free DNA, offering a promising new method for ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

A new study may finally change how amyotrophic lateral sclerosis (ALS) is diagnosed. Scientists from UCLA Health and the ...

A heart transplant recipient safely carried a baby to term using noninvasive DNA monitoring—marking a new milestone in maternal and transplant care.

Salivary cell-free mitochondrial DNA may serve as a non-invasive, low-cost biomarker for early Alzheimer’s detection before cognitive decline begins.

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it has been named ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

New research by UCLA Health has found a simple blood test could provide faster and more accurate diagnosis of ALS by ...

The prenatal and newborn genetic testing market is expanding due to technological advancements in non-invasive methods, rising awareness of genetic disorders, and supportive policies. Key ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that it will host a ...

The Human Genome Project, launched in 1990 and completed in 2003, also moved the needle. Scientists had successfully ...